$GFMH
Goliath Film & Media Holdings

2022 Q3 Form 10-K Financial Statement

#000149315222020601 Filed on July 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $17.06K $67.34K $95.58K
YoY Change 25.81% 709.38% 164.47%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $17.06K $67.34K $95.58K
YoY Change 25.78% 709.38% 164.48%
Operating Profit -$17.06K -$67.34K -$95.58K
YoY Change 25.78% 709.38% -4391.83%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.06K -$67.34K -$95.58K
YoY Change 25.78% 709.38% -4391.83%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$17.06K -$67.34K -$95.58K
YoY Change 25.78% 709.38% -4391.83%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$122.80 -$484.60 -$687.80
COMMON SHARES
Basic Shares Outstanding 139.0M shares 177.1M shares
Diluted Shares Outstanding 177.1M shares 177.1M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.00 $200.00 $200.00
YoY Change -90.83% -98.62% -98.62%
Cash & Equivalents $197.00 $198.00
Short-Term Investments
Other Short-Term Assets $300.00 $300.00 $300.00
YoY Change 0.0% 0.0% 0.0%
Inventory
Prepaid Expenses $299.00
Receivables
Other Receivables
Total Short-Term Assets $496.00 $497.00 $500.00
YoY Change -80.0% -96.65% -96.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $496.00 $497.00 $500.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $496.00 $497.00 $500.00
YoY Change -80.0% -96.65% -96.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.6K $106.1K $106.1K
YoY Change 53.89% 29.54% 29.54%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $194.3K $177.3K $177.3K
YoY Change 99.86% 84.6% 84.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $194.3K $177.3K $177.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $194.3K $177.3K $177.3K
YoY Change 99.86% 84.6% 84.6%
SHAREHOLDERS EQUITY
Retained Earnings -$1.166M -$1.149M
YoY Change 9.08%
Common Stock $139.0K $139.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$193.8K -$176.8K -$176.8K
YoY Change
Total Liabilities & Shareholders Equity $496.00 $497.00 $500.00
YoY Change -80.0% -96.65% -96.63%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$17.06K -$67.34K -$95.58K
YoY Change 25.78% 709.38% -4391.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.851K -$4.440K -$22.82K
YoY Change -76.46% -81.43% -258.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.850K 4.240K $8.485K
YoY Change -3.75%
NET CHANGE
Cash From Operating Activities -$3.851K -4.440K -$22.82K
Cash From Investing Activities 0.000
Cash From Financing Activities $3.850K 4.240K $8.485K
Net Change In Cash -$1.00 -200.0 -$14.34K
YoY Change -99.99% -99.16% -199.7%
FREE CASH FLOW
Cash From Operating Activities -$3.851K -$4.440K -$22.82K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000820771
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2021Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
81910 usd
CY2022Q2 us-gaap Assets
Assets
497 usd
CY2021Q2 us-gaap Assets
Assets
14833 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
0-18945
CY2022 dei Entity Registrant Name
EntityRegistrantName
GOLIATH FILM AND MEDIA HOLDINGS
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1055077
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
112 N. Curry Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Carson City
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89703
CY2022 dei City Area Code
CityAreaCode
(310)
CY2022 dei Local Phone Number
LocalPhoneNumber
467-0721
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
CY2022 dei Trading Symbol
TradingSymbol
GFMH
CY2021Q4 dei Entity Public Float
EntityPublicFloat
468860 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
138964917 shares
CY2022 dei Auditor Firm
AuditorFirmId
3627
CY2022 dei Auditor Name
AuditorName
Sadler, Gibb & Associates, LLC
CY2022 dei Auditor Location
AuditorLocation
Draper, UT
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14534 usd
CY2022Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
299 usd
CY2021Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
299 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
497 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
14833 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
71162 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14119 usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
106110 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
177272 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
96029 usd
CY2022Q2 us-gaap Liabilities
Liabilities
177272 usd
CY2021Q2 us-gaap Liabilities
Liabilities
96029 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138964917 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138964917 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
138966 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
138966 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
451500 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
451500 usd
CY2022Q2 GFMH Common Stock To Be Issued
CommonStockToBeIssued
381532 usd
CY2021Q2 GFMH Common Stock To Be Issued
CommonStockToBeIssued
381532 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1148773 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1053194 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-176775 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-81196 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
497 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14833 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38366 usd
CY2021 us-gaap Gross Profit
GrossProfit
38366 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
95579 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36139 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
95579 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
36139 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-95579 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2227 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95579 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2227 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-95579 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2227 usd
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-176775 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-83423 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2227 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-81196 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-81196 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-95579 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-95579 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-176775 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-95579 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2227 usd
CY2022 GFMH Expenses Paid On Behalf Of Company Related Party
ExpensesPaidOnBehalfOfCompanyRelatedParty
18715 usd
CY2021 GFMH Expenses Paid On Behalf Of Company Related Party
ExpensesPaidOnBehalfOfCompanyRelatedParty
29560 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-3000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-15000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
57043 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2408 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22821 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14379 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8485 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8485 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14336 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14379 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14534 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14534 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2022Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
38153269 shares
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zaZ127yaFaNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zmaJ4itfhwKf">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on the Company’s financial condition and results of operations during the period in which such changes occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual results could differ from those estimates. The Company’s financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38366 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zXgo3XMTKgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zfodUHMNAcK6">Concentrations, Risks, and Uncertainties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no customers constituting greater than <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_uPure_c20210501__20220430__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_znvi3eaj5S47" title="Concentration risk, percentage">10%</span> of the Company’s revenue in 2022. The Company has one customer, Mar Vista, that accounted for all of the Company’s gross sales during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no suppliers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_uPure_c20210501__20220430__srt--MajorCustomersAxis__custom--NoSuppliersMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SuppliersConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zHh3FwnRuFP4" title="Concentration risk, percentage">10%</span> or more of total expenditures for the fiscal years ended April 30, 2022 and 2021. There were no suppliers that accounted for <span><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_uPure_c20210501__20220430__srt--MajorCustomersAxis__custom--NoSuppliersMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SuppliersConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zVu4kGVaL061" title="Concentration risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_uPure_c20200501__20210430__srt--MajorCustomersAxis__custom--NoSuppliersMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SuppliersConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zjcyOzNJTTIi" title="Concentration risk, percentage">10%</span></span></span> or more of accounts payable at April 30, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022 us-gaap Substantial Doubt About Going Concern Conditions Or Events
SubstantialDoubtAboutGoingConcernConditionsOrEvents
The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash or other current assets, nor does it have an established source of revenues sufficient to cover its operating costs, which raises substantial doubt about our ability to continue as a going concern for a period of 12 months from the issuance of these financial statements
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8485 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8485 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1149000 usd
CY2022 GFMH Operating Loss Carryforward Expiration Date
OperatingLossCarryforwardExpirationDate
2020 and 2037
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
321000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1149000 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1053000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
321000 usd
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
295000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
321000 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
295000 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.280 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.280 pure
CY2022 GFMH Percentage Of Residual Payments
PercentageOfResidualPayments
0.036 pure
CY2022 GFMH Residual Payments
ResidualPayments
3750 usd
CY2022 GFMH Balance Amount Of Residual Payments
BalanceAmountOfResidualPayments
55972 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd

Files In Submission

Name View Source Status
0001493152-22-020601-index-headers.html Edgar Link pending
0001493152-22-020601-index.html Edgar Link pending
0001493152-22-020601.txt Edgar Link pending
0001493152-22-020601-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
gfmh-20220430.xsd Edgar Link pending
gfmh-20220430_cal.xml Edgar Link unprocessable
gfmh-20220430_def.xml Edgar Link unprocessable
gfmh-20220430_lab.xml Edgar Link unprocessable
gfmh-20220430_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending